- Home
- NEO vs TFIN Comparison
NEO vs TFIN Comparison
Compare NEO & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- TFIN
- Stock Information
- Founded
- NEO 2001
- TFIN 1981
- Country
- NEO United States
- TFIN United States
- Employees
- NEO N/A
- TFIN N/A
- Industry
- NEO Precision Instruments
- TFIN Major Banks
- Sector
- NEO Health Care
- TFIN Finance
- Exchange
- NEO Nasdaq
- TFIN Nasdaq
- Market Cap
- NEO 1.1B
- TFIN 1.2B
- IPO Year
- NEO 1999
- TFIN N/A
- Fundamental
- Price
- NEO $9.15
- TFIN $48.47
- Analyst Decision
- NEO Buy
- TFIN Hold
- Analyst Count
- NEO 10
- TFIN 4
- Target Price
- NEO $12.56
- TFIN $70.75
- AVG Volume (30 Days)
- NEO 3.0M
- TFIN 220.6K
- Earning Date
- NEO 10-28-2025
- TFIN 10-15-2025
- Dividend Yield
- NEO N/A
- TFIN N/A
- EPS Growth
- NEO N/A
- TFIN N/A
- EPS
- NEO N/A
- TFIN 0.44
- Revenue
- NEO $689,189,000.00
- TFIN $409,227,000.00
- Revenue This Year
- NEO $10.40
- TFIN $12.07
- Revenue Next Year
- NEO $10.11
- TFIN $14.74
- P/E Ratio
- NEO N/A
- TFIN $110.33
- Revenue Growth
- NEO 9.70
- TFIN 2.49
- 52 Week Low
- NEO $4.72
- TFIN $42.90
- 52 Week High
- NEO $19.12
- TFIN $110.58
- Technical
- Relative Strength Index (RSI)
- NEO 67.00
- TFIN 29.12
- Support Level
- NEO $7.56
- TFIN $47.41
- Resistance Level
- NEO $9.24
- TFIN $50.43
- Average True Range (ATR)
- NEO 0.36
- TFIN 1.88
- MACD
- NEO 0.06
- TFIN -0.60
- Stochastic Oscillator
- NEO 92.86
- TFIN 0.91
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.